$3SBIO(01530.HK) This recent wave has been moving a bit sluggishly. -0.47% isn't a lot, but it's not nothing either. However, this kind of slow, steady decline is even more of a headache... The pharmaceutical sector was thought to have exhausted its negative news and could recover, but it's still dragging its feet like this.
3SBIO
01530----
Share your thoughts
What's on your mind?
0 / 2,000
- H
Hot trades in Hong Kong stocks (7.29)｜Xiaomi's stock price hits a 1-month low, while innovative drug concepts buck the trend and rise!
The three major Hong Kong stock indices collectively retreated. WuXi AppTec's performance ignited the CRO sector, while tech stocks faced pressure, dragging down the indices.
- H
Hot Trades in Hong Kong Stocks (7.28)｜Cryptocurrency, Innovative Drugs, Insurance, and Gaming Sectors Shine, Hengrui Pharmaceuticals Soars 15% at Midday
Hong Kong stocks continued their upward trend on July 28, with the cryptocurrency, innovative drug, gaming, and insurance sectors performing well. Hong Kong's "Stablecoin Ordinance" will officially take effect on August 1, marking the countdown to stablecoin issuance; the innovative drug sector was boosted by Hengrui Pharmaceuticals securing a $12 billion order; insurance stocks extended their gains as industry anti-internal competition and interest rate cuts improved profit prospects; gaming stocks benefited from Macau's July gaming revenue exceeding expectations and Thailand's withdrawal of the casino bill.
- H
Hong Kong stocks' innovative drugs surge 66%! Three major catalysts ignite the 'golden track', can we still get on board in the second half of the year?
Hong Kong stocks' innovative medicine sector surges 66%, three-pronged approach ignites the golden track